New information about efficacy and safety of Alpharadin

Recently, two posters were presented at the European Society  of Clinical Oncology.  These posters reveal new information derived from a Phase III Alpharadin study.

For the Ask Dr Barken Call In Show on Tuesday, Oct. 30th at 6pm Pacific
Dial 1-877-727-3301 to hear the program and speak with Dr. Barken.
This entry was posted in Treatments for Prostate Cancer. Bookmark the permalink.